GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Pyrrolosporin A

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2666Pyrrolosporin AP388 leukemiaDose, ip (mg/kg/inj)\nEffect (% T/C)135 ToxicTreatment schedule: QD 1 to 5 days10.7164/antibiotics.49.865
act2667Pyrrolosporin AP388 leukemiaDose, ip (mg/kg/inj)\nEffect (% T/C)45 135Treatment schedule: QD 1 to 5 days10.7164/antibiotics.49.865
act2668Pyrrolosporin AP388 leukemiaDose, ip (mg/kg/inj)\nEffect (% T/C)15 130Treatment schedule: QD 1 to 5 days10.7164/antibiotics.49.865
act2669Pyrrolosporin AEnterococcus faecalis A20688MIC (µg/ml)410.7164/antibiotics.49.865
act2670Pyrrolosporin AE. faecalis ATCC 29212 MIC (µg/ml)410.7164/antibiotics.49.865
act2671Pyrrolosporin AE. faecalis ATCC 33186MIC (µg/ml)410.7164/antibiotics.49.865
act2672Pyrrolosporin AStaphylococcus aureus A9537MIC (µg/ml)0.510.7164/antibiotics.49.865
act2673Pyrrolosporin AS. aureus A20698MIC (µg/ml)110.7164/antibiotics.49.865
act2674Pyrrolosporin AS. aureus ATCC 29213MIC (µg/ml)0.510.7164/antibiotics.49.865
act2675Pyrrolosporin ABacillus subtilis ATCC 6633MIC (µg/ml)210.7164/antibiotics.49.865
act2676Pyrrolosporin AEscherichia coli A15119MIC (µg/ml)12510.7164/antibiotics.49.865
act2677Pyrrolosporin AE. coli A20697MIC (µg/ml)12510.7164/antibiotics.49.865
act2678Pyrrolosporin AE. coli ATCC 33176MIC (µg/ml)6310.7164/antibiotics.49.865
act2679Pyrrolosporin AKlebsiella pneumoniae A9664MIC (µg/ml)12510.7164/antibiotics.49.865
act2680Pyrrolosporin AK. pneumoniae A20468MIC (µg/ml)12510.7164/antibiotics.49.865
act2681Pyrrolosporin AProteus vulgaris A21559MIC (µg/ml)12510.7164/antibiotics.49.865
act2682Pyrrolosporin APseudomonas aeruginosa A9843MIC (µg/ml)6310.7164/antibiotics.49.865
act2683Pyrrolosporin AP. aeruginosa ATCC 27853MIC (µg/ml)12510.7164/antibiotics.49.865